Neuroendocrine cells of the verumontanum: A comparative immunohistochemical study

British Journal of Urology

Volumn 82, Issue 5, 1998, Pages 738-743

  Guy, L ^a   Begin, L R ^a   Al Othman, K ^a   Chevalier, S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anatomy; Ejaculatory ducts; Histology; Neurosecretory systems; Prostate

Indexed keywords

ANTIANDROGEN; BLOOD CLOTTING FACTOR 8; CHROMOGRANIN A; PROSTATE SPECIFIC ANTIGEN; SEROTONIN; VASCULOTROPIN;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; EJACULATORY DUCT; ENDOMETRIOID CARCINOMA; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROSECRETORY CELL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; UTRICLE; VASCULARIZATION;

CHROMOGRANIN A; CHROMOGRANINS; EJACULATORY DUCTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEUROSECRETORY SYSTEMS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEROTONIN;

EID: 0031736597     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00812.x     Document Type: Article

References (32)

1. McNeal JE. Regional morphology and pathology of the prostate. Am ] Clin Pathol 1968; 49: 347-57
2. Melicow MM, Pachter MR. Endometrial carcinoma of prostatic utricle (uterus masculinus). Cancer 1967: 20: 1715-22
3. Melicow MM, Tannenbaum M. Endometrial carcinoma of uterus masculinus (prostatic utricle). A report of 6 cases. J Ural 1971: 106: 892-902
4. Carney JA. Kelalis PP. Endometrial carcinoma of the prostatic utricle. Am }Clin Pathol 1973: 60: 565-9
5. Merchant RT Jr. Graham AR, Bucher WC Jr. Parker DA. Endometrial carcinoma of prostatic utricle with osseous métastases. Uroloyy 1976: 8: 169-73
6. Belter LP. Dodson AI Jr. Papillomatosis and papillary adenocarcinoma of prostatic ducts: a case report. J Urol 1970: 104: 880-3
7. Young BW. Lagios MD. Endometrial (papillary) carcinoma of the prostatic utricle -response to orchiectomy. Cancer 1973: 32: 1293-300
8. Zaloudek C. Williams JW. Kempson RL. 'Endometrial' adenocarcinoma of the prostate: a distinctive tumor of probable prostatic duct origin. Cancer 1976; 17: 2255-62
9. Bostwick DG. Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Am }Surg Pathol 1985; 9: 595-609
10. Sufrin G, Gaeta J. Staubitz WJ, Ajrawat HS. Murphy GP. Endometrial carcinoma of prostate. Urology 1986; 27: 18-23
11. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features. Cancer 1986: 57: 111-9
12. Wernert N. Luchtrath H. Seeliger H. Schafer M, Goebbels R. Dhom G. Papillary carcinoma of the prostate, location, morphology and immunohistochemistry: the histogenesis and entity of so-called endometrioid carcinoma. Prostate 1987: 10: 123-31
13. 3 di Sant'Agnese PA. de Mesy Jensen KL. Churkian CJ. Agarwal MM. Human prostatic endocrine-paracrine (APUD) cells. Distributional analysis with a comparison of serotonin and neuron specific enolase immunoreactivity and silver stains. Arch Pathol lab Med 1985: 109: 607-12
14. Cohen RJ. Glezerson G. Taylor LF. Grundle HAJ. Naudé JH. The neuroendocrine cell population of the human prostate gland. J Urol 1993; 150: 365-8
15. Harper ME. Glynne-Jones E. Goddard L. Thurston VJ. Griffiths K. Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. Br }Cancer 1996: 74: 910-6
16. Aprikian A. Cordon-Cardo C. Fair W, Reuter V. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma. Cancer 1993; 71: 3952-65
17. di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992: 23: 287-96
18. Krijnen JL. Janssen PJ. Ruizeveld de Winter JA. van Krimpen H. Schröder FH. van der Kwast TH. Do neuroendocrine cells in human prostate cancer express androgen receptor? Histochem 1993; 100: 393-8
19. Bonkhoff H. Stein U, Remberger K. Androgen receptor status in endocrine-paracrine cell types of the normal. hyperplastic, and neoplastic human prostate. Virchows Arch a Pathol Anat Histopathol 1993: 423: 291-4
20. Nakada SY. di Sant'Agnese PA. Moynes RA et al. The androgen status of neuroendocrine cells in human benign and malignant prostatic tissue. Cancer Res 1993: 53: 1967-70
21. Murphy WM. Soloway MS. Barrows GH. Pathologicchanges associated with androgen deprivation therapy for prostate cancer. Cancer 1991: 68: 821-8
22. Stridsberg M, Fabiani R. Lukinius A. Ronquist G. Prostasomes are neuroendocrine-like vesicle in human semen. Prostate 1996: 29: 287-95
23. Maier U. Woloszczuk W. Schuh H. Zechner (). Calcitonin and katacalcin-like immunoreactivity in human seminal plasma. Exp Clin Endocrinol 1986: 88: 89-94
24. Gnessi L. Ulisse S. Fabrri A et al. Isolation of a human seminal plasma peptide with bombesin-like activity. Fertil Steril 1989: 51: 1034-9
25. Sasaki A. Yoshinaga K. Imunoreactive somatostatin in male reproductive system in humans. J Clin Endocrinol Metab 1989: 68: 996-9
26. Fraioli F. Fabbri A. Gnessi L. Beta-endorphin. Metenkephalin and calcitonin in human semen: evidence for a possible role in human sperm motility. Arm N Y Acad Sei 1987: 438: 365-70
27. Iwamura M. Abrahamsson PA. Schoen S. Cockett AT. Deftos LJ. Immunoreactive parathyroid hormone-related protein is present in human seminal plasma and is of prostate origin. J Androl 1994: 1 5: 410-4
28. Stegmayr B. Ronquist G. Promotive effect on human sperm progressive motility by prostasomes. llrol Rex 1982; 10: 253-7
29. Fabiani R. ]ohansson L. Lundkvist 0, Ulmsten U. Ronquist G. Promotive effect by prostasomes on normal human spermatozoa exhibiting no forward motility due to buffer washings. Eur] Obstet Gi/necol Reprod Biol 1994: 57: 181-8
30. Wernert N. Kern L, Heitz P et al. Morphological and immunohistochemical investigations of the utriculus prostaticus from the fetal period to adulthood. Prostate 1990; 17: 19
31. Keck PJ. Hauser SD. Krivi G et ni. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989: 246: 1309
32. Senger DR. Galli SJ. Dvorak AM. Peruzzi CA. Harvey VS. Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983: 219: 983